Glyco-engineered Long Acting FGF21 Variant with Optimal Pharmaceutical and Pharmacokinetic Properties to Enable Weekly to Twice Monthly Subcutaneous Dosing

References

Page 1

	Year	Citations
FGF-21 as a novel metabolic regulator Alexei Kharitonenkov, Tatiyana L. Shiyanova, Anja Köester, Journal of Clinical Investigation ObesityMetabolic SyndromeNovel Metabolic RegulatorMetabolic DisorderMedicine	2005	2.1K
Endocrine Regulation of the Fasting Response by PPARα-Mediated Induction of Fibroblast Growth Factor 21 Takeshi Inagaki, Paul A. Dutchak, Guixiang Zhao, Cell Metabolism Molecular PhysiologyGrowth HormoneEndocrine MechanismHuman GrowthPhysiology	2007	1.5K
Fibroblast Growth Factor 21 Reverses Hepatic Steatosis, Increases Energy Expenditure, and Improves Insulin Sensitivity in Diet-Induced Obese Mice Jing Xu, David J. Lloyd, Clarence Hale, Diabetes	2008	1.1K
Fibroblast Growth Factor 21 Corrects Obesity in Mice Tamer Coşkun, Holly A. Bina, M. Schneider, Endocrinology NutritionMetabolic DisorderCorrects ObesityImmunologyFatty Liver Disease	2008	1K
The Effects of LY2405319, an FGF21 Analog, in Obese Human Subjects with Type 2 Diabetes Gregory Gaich, Jenny Y. Chien, Haoda Fu, Cell Metabolism ObesityMetabolic SyndromeHealth SciencesMetabolic DisorderMedicine	2013	867
The Metabolic State of Diabetic Monkeys Is Regulated by Fibroblast Growth Factor-21 Alexei Kharitonenkov, Victor J. Wroblewski, Anja Köester, Endocrinology Metabolic RemodelingInsulin SignalingObesityMetabolic SyndromeBody Composition	2006	729
Tissue-specific Expression of βKlotho and Fibroblast Growth Factor (FGF) Receptor Isoforms Determines Metabolic Activity of FGF19 and FGF21 Hiroshi Kurosu, Mihwa Choi, Yasushi Ogawa, Journal of Biological Chemistry Metabolic RemodelingFgf21 BindInsulin SignalingFgf ReceptorsMetabolic Syndrome	2007	720
The binding site for C1q on IgG Alexander Duncan, Greg Winter Nature Particle PhysicsBinding Site	1988	562
Enhancement of therapeutic protein in vivo activities through glycoengineering Steve Elliott, Tony Lorenzini, Sheilah Asher, Nature Biotechnology MedicineGlycobiologyBioconjugationProtein EngineeringTherapeutic Protein	2003	509
A Long-Acting FGF21 Molecule, PF-05231023, Decreases Body Weight and Improves Lipid Profile in Non-human Primates and Type 2 Diabetic Subjects Saswata Talukdar, Yingjiang Zhou, Dongmei Li, Cell Metabolism ObesityMetabolic SyndromeLong-acting Fgf21 MoleculeGrowth HormoneMetabolic Disorder	2016	477

Page 1